deltasone- Prednisone tablet United States - English - NLM (National Library of Medicine)

deltasone- prednisone tablet

pharmacia and upjohn and company - prednisone (unii: vb0r961hzt) (prednisone - unii:vb0r961hzt) - tablet - 2.5 mg - deltasone tablets are indicated in the following conditions: systemic fungal infections and known hypersensitivity to components.

DELTASONE- prednisone tablet United States - English - NLM (National Library of Medicine)

deltasone- prednisone tablet

oculus innovative sciences - prednisone (unii: vb0r961hzt) (prednisone - unii:vb0r961hzt) -

DELTASONE- prednisone tablet United States - English - NLM (National Library of Medicine)

deltasone- prednisone tablet

sonoma pharmaceuticals, inc. - prednisone (unii: vb0r961hzt) (prednisone - unii:vb0r961hzt) - prednisone tablets and solutions are indicated in the following conditions: primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice: synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance); congenital adrenal hyperplasia; hypercalcemia associated with cancer; nonsuppurative thyroiditis. as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: psoriatic arthritis, rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy), ankylosing spondylitis, acute and subacute bursitis, acute nonspecific tenosynovitis, acute gouty arthritis, post-traumatic osteoarthritis, synovitis of osteoarthritis, epicondylitis. during an exacerbation or as maintenance therapy in selected cases of: systemic lupus erythematosus, systemic dermatomyositis (polymyositis), acut